✦ LIBER ✦

P.4.a.006 A fixed dose study of the efficacy and safety of duloxetine for the treatment of generalised anxiety disorder

✍ Scribed by H. Koponen; C. Allgulander; Y.L. Pritchett; J. Erickson; M.J. Detke; S. Ball; J.M. Russell

Book ID: 118593009
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 63 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70587-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.4.a.009 Efficacy of pregabalin in gene

P.4.a.009 Efficacy of pregabalin in generalised social anxiety disorder: results of a placebo-controlled, fixed-dose study

✍ D. Feltner; R. Bielski; M. Liu-Dumaw 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Efficacy and safety of duloxetine in the

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial

✍ Moira Rynn; James Russell; Janelle Erickson; Michael J. Detke; Susan Ball; Jeff 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

A Double-Blind Efficacy and Safety Study

A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder

✍ Emslie, Graham J.; Prakash, Apurva; Zhang, Qi; Pangallo, Beth A.; Bangs, Mark E. 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 484 KB

P.4.a.020 Efficacy and safety of pregaba

P.4.a.020 Efficacy and safety of pregabalin for the treatment of generalized anxiety disorder in elderly patients

✍ S.A. Montgomery; K. Chatamra; F. Baldinetti; E. Whalen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Duloxetine for the treatment of major de

Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range

✍ Craig H. Mallinckrodt; Apurva Prakash; Anne C. Andorn; John G. Watkin; Madelaine 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Duloxetine for the treatment of major de

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

✍ Madelaine M. Wohlreich; Craig H. Mallinckrodt; Apurva Prakash; John G. Watkin; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views